Year |
Citation |
Score |
2023 |
Prabhakar A, Kumar R, Wadhwa M, Ghatpande P, Zhang J, Zhao Z, Lizama CO, Kharbikar BN, Gräf S, Treacy CM, Morrell NW, Graham BB, Lagna G, Hata A. Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response. Biorxiv : the Preprint Server For Biology. PMID 38076809 DOI: 10.1101/2023.11.27.568924 |
0.718 |
|
2023 |
Prabhakar A, Hu S, Tang J, Ghatpande P, Lagna G, Jiang X, Hata A. Essential role of the amino-terminal region of Drosha for the Microprocessor function. Iscience. 26: 107971. PMID 37810246 DOI: 10.1016/j.isci.2023.107971 |
0.748 |
|
2021 |
Hata A, Lagna G. How do you mend inactive tumor suppressor mutants? You glue them! Cell Chemical Biology. 28: 585-587. PMID 34019843 DOI: 10.1016/j.chembiol.2021.04.023 |
0.678 |
|
2021 |
Jiang X, Prabhakar A, Van der Voorn SM, Ghatpande P, Celona B, Venkataramanan S, Calviello L, Lin C, Wang W, Black BL, Floor SN, Lagna G, Hata A. Control of ribosomal protein synthesis by the Microprocessor complex. Science Signaling. 14. PMID 33622983 DOI: 10.1126/scisignal.abd2639 |
0.702 |
|
2020 |
Oda Y, Nguyen T, Hata A, Meyer MB, Pike JW, Bikle DD. Deletion of Mediator 1 suppresses TGFβ signaling leading to changes in epidermal lineages and regeneration. Plos One. 15: e0238076. PMID 32857768 DOI: 10.1371/Journal.Pone.0238076 |
0.43 |
|
2019 |
Hata A, Lagna G. Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia. Current Opinion in Hematology. PMID 30855334 DOI: 10.1097/Moh.0000000000000493 |
0.74 |
|
2018 |
Vattulainen-Collanus S, Southwood M, Yang XD, Moore S, Ghatpande P, Morrell NW, Lagna G, Hata A. Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells. Communications Biology. 1: 149. PMID 30272025 DOI: 10.1038/s42003-018-0152-1 |
0.729 |
|
2018 |
Kameny RJ, He Y, Zhu T, Gong W, Raff GW, Chapin CJ, Datar SA, Boehme J, Hata A, Fineman JR. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease. American Journal of Physiology. Heart and Circulatory Physiology. PMID 29906222 DOI: 10.1152/Ajpheart.00057.2018 |
0.432 |
|
2018 |
Jiang X, Wooderchak-Donahue WL, McDonald J, Ghatpande P, Baalbaki M, Sandoval M, Hart D, Clay H, Coughlin S, Lagna G, Bayrak-Toydemir P, Hata A. Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia. Science Signaling. 11. PMID 29339534 DOI: 10.1126/Scisignal.Aan6831 |
0.771 |
|
2017 |
Kashima R, Hata A. The role of TGF-β superfamily signaling in neurological disorders. Acta Biochimica Et Biophysica Sinica. 1-15. PMID 29190314 DOI: 10.1093/Abbs/Gmx124 |
0.376 |
|
2017 |
Caruso P, Dunmore BJ, Schlosser K, Schoors S, Dos Santos CC, Perez-Iratxeta C, Lavoie JR, Zhang H, Long L, Flockton AR, Frid MG, Upton PD, D'Alessandro A, Hadinnapola C, Kiskin FN, ... ... Hata A, et al. Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2. Circulation. PMID 28971999 DOI: 10.1161/Circulationaha.117.028034 |
0.489 |
|
2017 |
Jiang X, Hawkins JS, Lee J, Lizama CO, Bos FL, Zape JP, Ghatpande P, Peng Y, Louie J, Lagna G, Zovein AC, Hata A. Let-7 microRNA-dependent control of leukotriene signaling regulates the transition of hematopoietic niche in mice. Nature Communications. 8: 128. PMID 28743859 DOI: 10.1038/S41467-017-00137-Y |
0.733 |
|
2017 |
Kashima R, Redmond PL, Ghatpande P, Roy S, Kornberg TB, Hanke T, Knapp S, Lagna G, Hata A. Hyperactive locomotion in a Drosophila model is a functional readout for the synaptic abnormalities underlying fragile X syndrome. Science Signaling. 10. PMID 28465421 DOI: 10.1126/Scisignal.Aai8133 |
0.719 |
|
2016 |
Hata A, Chen YG. TGF-β Signaling from Receptors to Smads. Cold Spring Harbor Perspectives in Biology. PMID 27449815 DOI: 10.1101/Cshperspect.A022061 |
0.408 |
|
2016 |
Kashima R, Roy S, Ascano M, Martinez-Cerdeno V, Ariza-Torres J, Kim S, Louie J, Lu Y, Leyton P, Bloch KD, Kornberg TB, Hagerman PJ, Hagerman R, Lagna G, Hata A. Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome. Science Signaling. 9: ra58. PMID 27273096 DOI: 10.1126/Scisignal.Aaf6060 |
0.736 |
|
2016 |
Kang H, Hata A. Quantitative Real-Time PCR Analysis of MicroRNAs and Their Precursors Regulated by TGF-β Signaling. Methods in Molecular Biology (Clifton, N.J.). 1344: 313-23. PMID 26520134 DOI: 10.1007/978-1-4939-2966-5_20 |
0.348 |
|
2016 |
Caruso P, Dunmore B, Schlosser K, Schoors S, Santos CD, Perez-Iratxeta C, Lavoie J, Long L, Hurst L, Ormiston M, Hata A, Carmeliet P, Stewart D, Morrell N. S84 Identification of MIR-124a as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension Thorax. 71: A48.2-A49. DOI: 10.1136/Thoraxjnl-2016-209333.90 |
0.489 |
|
2015 |
Hata A, Kashima R. Dysregulation of microRNA biogenesis machinery in cancer. Critical Reviews in Biochemistry and Molecular Biology. 1-14. PMID 26628006 DOI: 10.3109/10409238.2015.1117054 |
0.389 |
|
2015 |
Morrell NW, Bloch DB, Ten Dijke P, Goumans MT, Hata A, Smith J, Yu PB, Bloch KD. Targeting BMP signalling in cardiovascular disease and anaemia. Nature Reviews. Cardiology. PMID 26461965 DOI: 10.1038/Nrcardio.2015.156 |
0.437 |
|
2015 |
Cushing L, Costinean S, Xu W, Jiang Z, Madden L, Kuang P, Huang J, Weisman A, Hata A, Croce CM, Lü J. Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature. Plos Genetics. 11: e1005238. PMID 26020233 DOI: 10.1371/Journal.Pgen.1005238 |
0.461 |
|
2015 |
Hata A, Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Science Signaling. 8: re3. PMID 25783160 DOI: 10.1126/Scisignal.2005825 |
0.414 |
|
2015 |
Hata A, Kang H. Functions of the bone morphogenetic protein signaling pathway through microRNAs (review). International Journal of Molecular Medicine. 35: 563-8. PMID 25571950 DOI: 10.3892/Ijmm.2015.2060 |
0.53 |
|
2015 |
Kang H, Hata A. The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesis. Bmb Reports. 48: 319-23. PMID 25341923 DOI: 10.5483/Bmbrep.2015.48.6.206 |
0.448 |
|
2014 |
Kim S, Hata A, Kang H. Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation. Journal of Cellular Biochemistry. 115: 889-95. PMID 24375867 DOI: 10.1002/Jcb.24730 |
0.542 |
|
2013 |
Chang J, Davis-Dusenbery BN, Kashima R, Jiang X, Marathe N, Sessa R, Louie J, Gu W, Lagna G, Hata A. Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress Embo Journal. 32: 3192-3205. PMID 24219989 DOI: 10.1038/Emboj.2013.242 |
0.738 |
|
2013 |
Sessa R, Hata A. Role of microRNAs in lung development and pulmonary diseases. Pulmonary Circulation. 3: 315-28. PMID 24015331 DOI: 10.4103/2045-8932.114758 |
0.403 |
|
2013 |
Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, Spagnolli E, Martinez A, Ryan A, Tainsh LT, Kim S, Rong J, Huan T, Freedman JE, Levy D, ... ... Hata A, et al. Atrial natriuretic peptide is negatively regulated by microRNA-425. The Journal of Clinical Investigation. 123: 3378-82. PMID 23867623 DOI: 10.1172/Jci67383 |
0.556 |
|
2013 |
Blahna MT, Hata A. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Current Opinion in Cell Biology. 25: 233-40. PMID 23312066 DOI: 10.1016/J.Ceb.2012.12.005 |
0.488 |
|
2013 |
Hata A. Functions of microRNAs in cardiovascular biology and disease. Annual Review of Physiology. 75: 69-93. PMID 23157557 DOI: 10.1146/Annurev-Physiol-030212-183737 |
0.405 |
|
2013 |
Arora P, Wu C, Bloch DB, Davis-Dusenbury BN, Spagnolli E, Hata A, Vandenwijngaert S, Swinnen M, Janssens S, Buys ES, Bloch KD, Newton-Cheh C, Wang TJ. MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-O10 |
0.538 |
|
2012 |
Akhurst RJ, Hata A. Targeting the TGFβ signalling pathway in disease. Nature Reviews. Drug Discovery. 11: 790-811. PMID 23000686 DOI: 10.1038/Nrd3810 |
0.326 |
|
2012 |
Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery BN, Lagna G, Hata A. Inhibition of microRNA-302 (miR-302) by Bone Morphogenetic Protein 4 (BMP4) facilitates the BMP signaling pathway Journal of Biological Chemistry. 287: 38656-38664. PMID 22988237 DOI: 10.1074/Jbc.M112.390898 |
0.798 |
|
2012 |
Wang D, Prakash J, Nguyen P, Davis-Dusenbery BN, Hill NS, Layne MD, Hata A, Lagna G. Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A. The Journal of Biological Chemistry. 287: 28067-77. PMID 22718766 DOI: 10.1074/Jbc.M112.379487 |
0.754 |
|
2012 |
Kang H, Hata A. MicroRNA regulation of smooth muscle gene expression and phenotype. Current Opinion in Hematology. 19: 224-31. PMID 22406821 DOI: 10.1097/Moh.0B013E3283523E57 |
0.458 |
|
2012 |
Blahna MT, Hata A. Smad-mediated regulation of microRNA biosynthesis. Febs Letters. 586: 1906-12. PMID 22306316 DOI: 10.1016/J.Febslet.2012.01.041 |
0.481 |
|
2012 |
Hata A, Brivanlou AH. A taste of TGFβ in Tuscany. Development (Cambridge, England). 139: 449-53. PMID 22223676 DOI: 10.1242/Dev.067249 |
0.345 |
|
2012 |
Kang H, Davis-Dusenbery BN, Nguyen PH, Lal A, Lieberman J, Van Aelst L, Lagna G, Hata A. Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. The Journal of Biological Chemistry. 287: 3976-86. PMID 22158624 DOI: 10.1074/Jbc.M111.303156 |
0.77 |
|
2012 |
McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovascular Research. 93: 594-604. PMID 22065733 DOI: 10.1093/Cvr/Cvr299 |
0.46 |
|
2012 |
Massaous J, Hata A. TGF-beta signalling through the Smad pathway. Trends in Cell Biology. 7: 187-92. PMID 17708943 DOI: 10.1016/S0962-8924(97)01036-2 |
0.434 |
|
2012 |
Kang H, Hata A. Control of Drosha-Mediated MicroRNA Maturation by Smad Proteins The Enzymes. 32: 123-136. DOI: 10.1016/B978-0-12-404741-9.00006-4 |
0.448 |
|
2011 |
Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2370-7. PMID 22011749 DOI: 10.1161/Atvbaha.111.226670 |
0.648 |
|
2011 |
Wu C, So J, Davis-Dusenbery BN, Qi HH, Bloch DB, Shi Y, Lagna G, Hata A. Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2. Molecular and Cellular Biology. 31: 4760-74. PMID 21969601 DOI: 10.1128/Mcb.05776-11 |
0.78 |
|
2011 |
Hata A, Davis BN. Regulation of pri-miRNA Processing Through Smads. Advances in Experimental Medicine and Biology. 700: 15-27. PMID 21755469 DOI: 10.1007/978-1-4419-7823-3_2 |
0.77 |
|
2011 |
Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A. down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. The Journal of Biological Chemistry. 286: 28097-110. PMID 21673106 DOI: 10.1074/Jbc.M111.236950 |
0.801 |
|
2011 |
Davis-Dusenbery BN, Hata A. Smad-mediated miRNA processing: a critical role for a conserved RNA sequence. Rna Biology. 8: 71-6. PMID 21289485 DOI: 10.4161/Rna.8.1.14299 |
0.427 |
|
2011 |
Chan MC, Weisman AS, Kang H, Nguyen PH, Hickman T, Mecker SV, Hill NS, Lagna G, Hata A. The amiloride derivative phenamil attenuates pulmonary vascular remodeling by activating NFAT and the bone morphogenetic protein signaling pathway. Molecular and Cellular Biology. 31: 517-30. PMID 21135135 DOI: 10.1128/Mcb.00884-10 |
0.807 |
|
2010 |
Hata A, Davis BN. Regulation of pri-miRNA processing through Smads. Advances in Experimental Medicine and Biology. 700: 15-27. PMID 21627026 |
0.757 |
|
2010 |
Davis-Dusenbery BN, Hata A. MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways. Genes & Cancer. 1: 1100-14. PMID 21533017 DOI: 10.1177/1947601910396213 |
0.406 |
|
2010 |
Davis-Dusenbery BN, Hata A. Mechanisms of control of microRNA biogenesis. Journal of Biochemistry. 148: 381-92. PMID 20833630 DOI: 10.1093/Jb/Mvq096 |
0.424 |
|
2010 |
Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Molecular Cell. 39: 373-84. PMID 20705240 DOI: 10.1016/J.Molcel.2010.07.011 |
0.803 |
|
2010 |
Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G, Hata A. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. The Embo Journal. 29: 559-73. PMID 20019669 DOI: 10.1038/Emboj.2009.370 |
0.811 |
|
2009 |
Hata A, Davis BN. Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus. Cytokine & Growth Factor Reviews. 20: 517-21. PMID 19892582 DOI: 10.1016/J.Cytogfr.2009.10.004 |
0.782 |
|
2009 |
Davis BN, Hata A. Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Communication and Signaling : Ccs. 7: 18. PMID 19664273 DOI: 10.1186/1478-811X-7-18 |
0.782 |
|
2009 |
Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 15: 328-40. PMID 19345331 DOI: 10.1016/J.Ccr.2009.02.023 |
0.34 |
|
2009 |
Neuman NA, Ma S, Schnitzler GR, Zhu Y, Lagna G, Hata A. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone. The Journal of Biological Chemistry. 284: 13202-12. PMID 19265191 DOI: 10.1074/Jbc.M900282200 |
0.822 |
|
2009 |
Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. The Journal of Biological Chemistry. 284: 3728-38. PMID 19088079 DOI: 10.1074/Jbc.M808788200 |
0.821 |
|
2008 |
Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature. 454: 56-61. PMID 18548003 DOI: 10.1038/nature07086 |
0.82 |
|
2007 |
Lagna G, Ku MM, Nguyen PH, Neuman NA, Davis BN, Hata A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. The Journal of Biological Chemistry. 282: 37244-55. PMID 17947237 DOI: 10.1074/Jbc.M708137200 |
0.8 |
|
2007 |
Chan MC, Nguyen PH, Davis BN, Ohoka N, Hayashi H, Du K, Lagna G, Hata A. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Molecular and Cellular Biology. 27: 5776-89. PMID 17576816 DOI: 10.1128/Mcb.00218-07 |
0.806 |
|
2006 |
Lagna G, Nguyen PH, Ni W, Hata A. BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology. 291: L1059-67. PMID 17030903 DOI: 10.1152/Ajplung.00180.2006 |
0.737 |
|
2006 |
Ku M, Howard S, Ni W, Lagna G, Hata A. OAZ regulates bone morphogenetic protein signaling through Smad6 activation. The Journal of Biological Chemistry. 281: 5277-87. PMID 16373339 DOI: 10.1074/Jbc.M510004200 |
0.769 |
|
2005 |
Ku M, Sokol SY, Wu J, Tussie-Luna MI, Roy AL, Hata A. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors. Molecular and Cellular Biology. 25: 7144-57. PMID 16055724 DOI: 10.1128/Mcb.25.16.7144-7157.2005 |
0.317 |
|
2004 |
Seki K, Hata A. Indian hedgehog gene is a target of the bone morphogenetic protein signaling pathway. The Journal of Biological Chemistry. 279: 18544-9. PMID 14981086 DOI: 10.1074/Jbc.M311592200 |
0.438 |
|
2004 |
Bond HM, Mesuraca M, Carbone E, Bonelli P, Agosti V, Amodio N, De Rosa G, Di Nicola M, Gianni AM, Moore MA, Hata A, Grieco M, Morrone G, Venuta S. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood. 103: 2062-70. PMID 14630787 DOI: 10.1182/Blood-2003-07-2388 |
0.385 |
|
2003 |
Ku MC, Stewart S, Hata A. Poly(ADP-ribose) polymerase 1 interacts with OAZ and regulates BMP-target genes. Biochemical and Biophysical Research Communications. 311: 702-7. PMID 14623329 DOI: 10.1016/J.Bbrc.2003.10.053 |
0.389 |
|
2003 |
Seki K, Fujimori T, Savagner P, Hata A, Aikawa T, Ogata N, Nabeshima Y, Kaechoong L. Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. The Journal of Biological Chemistry. 278: 41862-70. PMID 12917416 DOI: 10.1074/Jbc.M308336200 |
0.366 |
|
2000 |
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massagué J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell. 100: 229-40. PMID 10660046 DOI: 10.1016/S0092-8674(00)81561-5 |
0.747 |
|
1998 |
Hata A, Shi Y, Massagué J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Molecular Medicine Today. 4: 257-62. PMID 9679244 DOI: 10.1016/S1357-4310(98)01247-7 |
0.4 |
|
1998 |
Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J. Determinants of specificity in TGF-β signal transduction Genes and Development. 12: 2144-2152. PMID 9679059 DOI: 10.1101/Gad.12.14.2144 |
0.393 |
|
1998 |
Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor Genes & Development. 12: 186-197. PMID 9436979 DOI: 10.1101/Gad.12.2.186 |
0.692 |
|
1997 |
Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4 Nature. 388: 87-93. PMID 9214508 DOI: 10.1038/40431 |
0.418 |
|
1997 |
Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 Nature. 388: 82-87. PMID 9214507 DOI: 10.1038/40424 |
0.714 |
|
1997 |
Wan Y, Bence K, Hata A, Kurosaki T, Veillette A, Huang XY. Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G protein signaling. The Journal of Biological Chemistry. 272: 17209-15. PMID 9202044 DOI: 10.1074/Jbc.272.27.17209 |
0.328 |
|
1997 |
Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes & Development. 11: 984-995. PMID 9136927 DOI: 10.1101/Gad.11.8.984 |
0.372 |
|
1996 |
Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 383: 832-6. PMID 8893010 DOI: 10.1038/383832A0 |
0.429 |
|
1996 |
Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature. 381: 620-3. PMID 8637600 DOI: 10.1038/381620A0 |
0.46 |
|
1992 |
Hata A, Ohno S, Suzuki K. Transcriptional activation of the gene for the large subunit of human m-calpain by 12-o-tetradecanoyl-phorbol-13-acetate. Febs Letters. 304: 241-4. PMID 1618329 DOI: 10.1016/0014-5793(92)80628-T |
0.302 |
|
1991 |
Ohno S, Akita Y, Hata A, Osada S, Kubo K, Konno Y, Akimoto K, Mizuno K, Saido T, Kuroki T. Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. Advances in Enzyme Regulation. 31: 287-303. PMID 1877391 DOI: 10.1016/0065-2571(91)90018-H |
0.383 |
|
1989 |
Hata A, Akita Y, Konno Y, Suzuki K, Ohno S. Direct evidence that the kinase activity of protein kinase C is involved in transcriptional activation through a TPA-responsive element. Febs Letters. 252: 144-6. PMID 2759229 DOI: 10.1016/0014-5793(89)80907-X |
0.332 |
|
Show low-probability matches. |